Atara Biotherapeutics (ATRA) Prepaid Assets (2013 - 2026)

Atara Biotherapeutics has reported Prepaid Assets for 14 years, with the latest figure at $3.8 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets fell 11.74% year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (down 11.74% YoY), and the FY2025 full-year result was $2.5 million, down 75.51% from the prior year.
• Prepaid Assets for Q1 2026 stood at $3.8 million, up from $2.5 million in the prior quarter.
• The five-year high for Prepaid Assets was $16.0 million in Q3 2022, with the low at $2.4 million in Q2 2025.
• Historically, Prepaid Assets has averaged $8.2 million across 5 years, with a median of $9.2 million in 2024.
• Annual changes were most pronounced in 2024 — Prepaid Assets soared 63.57% — and 2025, when it sank 75.51%.
• Atara Biotherapeutics' Prepaid Assets stood at $10.3 million in 2022, then slumped by 40.01% to $6.2 million in 2023, then surged by 63.57% to $10.1 million in 2024, then slumped by 75.51% to $2.5 million in 2025, then soared by 53.94% to $3.8 million in 2026.
• The last three Prepaid Assets figures came in at $3.8 million (Q1 2026), $2.5 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.